GKWIM
SGMO

Gerber Kawasaki Wealth & Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed -$1K – 951
2021
Q3 		$1K Buy
+1
New +$10 ﹤0.01% 1116

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's SGMO Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 1 share — an estimated $1K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in SGMO in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 1 SANGAMO THERAPEUTICS INC share in Q4 2021, an estimated $1K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's SANGAMO THERAPEUTICS INC position peaked at $1K in Q3 2021.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.